Approval · Notice of Compliance 29084 · 2022
SEMGLEE: Notice of Compliance 29084
Issued September 22, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 29084
- Date
- September 22, 2022
- Company
- BGP Pharma ULCEtobicoke, Ontario, Canada
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Labelling updates
- Canadian reference product
- LANTUS
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| SEMGLEE | Not yet assigned | — |
Medicinal ingredients
- INSULIN GLARGINE 100 UNIT per ML